flurbiprofen has been researched along with naproxen in 106 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (12.26) | 18.7374 |
1990's | 16 (15.09) | 18.2507 |
2000's | 33 (31.13) | 29.6817 |
2010's | 38 (35.85) | 24.3611 |
2020's | 6 (5.66) | 2.80 |
Authors | Studies |
---|---|
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Apiwattanakul, N; Chairoungdua, A; Endou, H; Kanai, Y; Nakajima, N; Sekine, T; Sophasan, S | 1 |
Duffy, EM; Jorgensen, WL | 1 |
Topliss, JG; Yoshida, F | 1 |
Cihlar, T; Ho, ES; Mulato, AS | 1 |
Chang, TK; Ensom, MH; Kiang, TK | 1 |
Caron, G; Ermondi, G | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bauer, R; Goeters, S; Hempel, B; Imming, P; Krause, E; Lohmann, K; Ramadan, M; Watzer, B | 1 |
Carrupt, PA; Martel, S; Ottaviani, G | 1 |
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Fujiwara, R; Koga, T; Nakajima, M; Yokoi, T | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U | 1 |
Kumar, M; Sinha, VR; Thareja, S | 1 |
Atwell, GJ; Brooke, DG; Denny, WA; Flanagan, JU; Hamilton, EJ; Heinrich, D; Jamieson, SM; Owen, PJ; Raynham, T; Rigoreau, LJ; Samlal, SS; Schroeder, E; Silva, S; Soudy, C; Trivier, E; Turnbull, AP | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Brewster, C; Deering-Rice, CE; Reilly, CA; Rose, TM | 1 |
Aytaç, PS; Çetin-Atalay, R; Durmaz, I; Houston, DR; Tozkoparan, B | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Pradalier, A; Vincent, D | 1 |
Goldhaber, P; Hall, CM; Howell, TH; Jeffcoat, MK; Johnson, HG; Odle, BM; Offenbacher, S; Smith, MA; Williams, RC | 1 |
Bidault, R; Haumont, M; Herber, R; Magdalou, J; Siest, G; van Es, H | 1 |
VanArsdel, PP | 1 |
Gupta, SK; Joshi, S | 1 |
Eissens, AC; Franssen, EJ; Frijlink, HW; Lerk, CF; Meijer, DK; Oosting, R | 1 |
Fritz, ME; Green, MD; Mayambala, CS; Odle, BM; Offenbacher, S; Sena, FJ; Smith, MA; van Dyke, TE; Yeh, KC | 1 |
Mayer, JM | 1 |
Atkinson, MH; Buchanan, WW; Fitzgerald, AA; Lussier, A; Tannenbaum, HH | 1 |
Andersch, B; Milsom, I | 1 |
Bartolucci, C; Maître, JM; Mayer, JM; Testa, B | 1 |
Andersch, B; Milsom, I; Sundell, G | 1 |
Denlinger, RH; Elliott, GA; Purmalis, A; VanderMeer, DA | 1 |
Crittenden, N; Fitzpatrick, F; McGee, J; McGuire, J | 1 |
Brown, BL; Johnson, JH; Stiger, TR | 1 |
Ansell, BM; Leak, AM; Richter, MR; St Cyr, CH | 1 |
Buchanan, WW; Kassam, YB | 1 |
Cherie-Ligniere, G; Colamussi, V; Cozzolongo, AC; Frizziero, L; Loizzi, P; Mattara, L; Zorzin, L | 1 |
Boss, G; Maître, JM; Testa, B | 1 |
Whittle, BJ | 1 |
Burry, HC; Siebers, R | 1 |
Chemtob, S; Hanna, N; Lachapelle, P; Orquin, J; Roy, MS; Varma, DR | 1 |
Armstrong, DW; Chen, JR; Rundlett, KL | 1 |
Deridder, G; Evrard, PA; Verbeeck, RK | 1 |
Borgå, B; Borgå, O | 1 |
el-Bary, AA; el-Nabarawi, MA; Mohamed, MI | 1 |
Antonelli, E; Cirino, G; Coata, G; Distrutti, E; Federici, B; Fiorucci, S; Morelli, A; Morelli, O; Renzo, GD; Santucci, L; Soldato, PD | 1 |
Hauer, MJ; Hutzler, JM; Tracy, TS | 1 |
Buchwald, SL; Moradi, WA | 1 |
Lozano, JJ; Pouplana, R; Ruiz, J | 1 |
Dickmann, LJ; Haining, RL; Hummel, MA; Hutzler, JM; Rettie, AE; Tracy, TS | 1 |
Kato, S; Kunikata, T; Miyazawa, T; Takeuchi, K; Tanaka, A | 1 |
Hummel, MA; Hutzler, JM; Kolwankar, D; Tracy, TS | 1 |
Lin, BC; Zhu, XF | 1 |
Dickmann, LJ; Haining, RL; Hummel, MA; Rettie, AE; Tracy, TS | 1 |
Chang, CE; Chen, W; Gilson, MK | 1 |
Breese, E; Del Soldato, P; Mitchell, J; Warner, T; Wood, E; Zacharowski, P | 1 |
Karaman, AI; Polat, O | 1 |
Gyllenhaal, O; Stefansson, M | 1 |
Takahira, Y; Takeuchi, K; Tanaka, A; Yokota, A | 1 |
Hornung, S; Krill, SL; Vippagunta, SR; Wang, Z | 1 |
El-Fayomi, HM; El-Sadek, ME; Lashine, el-SM; Metwally, KA; Yaseen, SH | 1 |
Balchen, M; Gjelstad, A; Pedersen-Bjergaard, S; Rasmussen, KE | 1 |
Ji, H; Peng, SX; Zhang, YH | 1 |
Abdel-Aziz, AA; El-Kamel, AH; El-Subbagh, HI; Fatani, AJ | 1 |
Cárdenas, S; Cruz-Vera, M; Lucena, R; Valcárcel, M | 1 |
Berber, MR; Katoh, M; Minagawa, K; Mori, T; Tanaka, M | 1 |
Fanali, S; Rocco, A | 1 |
Angeletti, M; Censi, R; Di Martino, P; Gashi, Z; Gobetto, R; Malaj, L; Masic, A; Mozzicafreddo, M | 1 |
Higashi, K; Ideura, S; Limwikrant, W; Moribe, K; Waraya, H; Yamamoto, K | 1 |
Higashi, K; Ideura, S; Moribe, K; Waraya, H; Yamamoto, K | 1 |
Aoki, Y; Honjo, H; Iwamoto, K; Uwai, Y | 1 |
Alcudia-León, MC; Cárdenas, S; Lucena, R; Riaño, S; Valcárcel, M | 1 |
Chai, MZ; Flanagan, JU; Squire, CJ; Teague, RM; Turnbull, AP; Yosaatmadja, Y | 1 |
Bouchet, LM; de la Guardia, M; Delgado-Pérez, T; Galian, RE; Pérez-Prieto, J | 1 |
Dong, L; Jurban, BJ; Sharma, NP; Smith, WL | 1 |
Björklund, E; Cipriano, M; Congiu, C; Fowler, CJ; Onnis, V; Wilson, AA | 1 |
Gaš, B; Riesová, M; Svobodová, J; Tošner, Z; Ušelová, K; Zusková, I | 1 |
Dimoglo, A; Erçetin, T; Esiringu, İ; Gülcan, HO; Öz, D; Şahin, MF; Şahin, Y; Ünlü, S | 1 |
Chen, Z; Fan, H; Huang, X; Luo, A; Wan, Q; Wu, X; Zang, L | 1 |
Barbera, L; Gattuso, G; Kohnke, FH; Micali, N; Notti, A; Pappalardo, S; Parisi, MF; Patanè, S; Pisagatti, I; Villari, V | 1 |
Funakami, Y; Kato, Y; Nagai, N; Tanino, T | 1 |
Cacciatore, I; Cerasa, LS; Costantini, E; D'Angelo, C; Di Stefano, A; Eusepi, P; Fornasari, E; Marinelli, L; Pomilio, C; Reale, M; Türkez, H | 1 |
Camacho-Muñoz, D; Kasprzyk-Hordern, B; Thomas, KV | 1 |
Higashi, K; Liu, N; Moribe, K; Ueda, K | 1 |
Donnelly, L; Gorman, SP; Hardy, JG; Irwin, NJ; Jones, DS; McCoy, CP | 1 |
Hachuła, B | 1 |
Canotilho, J; Castro, RAE; Eusébio, MES; Machado, SMT; Maria, TMR | 1 |
Iwaki, M; Kawase, A; Kobayashi, Y; Ogiso, T; Shimada, H; Tanahashi, S | 1 |
Ma, R; Qu, H; Wang, B; Wang, F; Yu, G; Yu, Y | 1 |
Agrawal, NR; Briber, RM; Domszy, R; Fan, X; Hu, N; Koolivand, A; Torres-Luna, C; Wang, NS; Yang, A; Zhu, Y | 1 |
Beller, M; Neumann, H; Sergeev, AG; Spannenberg, A | 1 |
Eichhorn, T; Hey-Hawkins, E; Kaluđerović, GN; Morgan, I; Predarska, I; Saoud, M | 1 |
Khan, SJ; Leusch, FDL; McDonald, JA; Neale, PA; Nghiem, LD; Nguyen, LN; Nguyen, QA; Vu, HP | 1 |
Gorenflo, M; Saur, P; van den Anker, JN; van Dyk, M; Welzel, T; Ziesenitz, VC | 1 |
Habara, M; Haraguchi, T; Ikezaki, H; Kawasaki, I; Kojima, H; Ohkawa, K; Ozeki, M; Uchida, T; Uno, R; Yoshida, M | 1 |
Bai, L; Guo, X; Liu, D; Liu, Y; Ma, Z; Nie, Y; Qiao, X; Shang, P; Wei, B | 1 |
7 review(s) available for flurbiprofen and naproxen
Article | Year |
---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Migraine and non-steroidal anti-inflammatory agents].
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diclofenac; Ergotamine; Flufenamic Acid; Flurbiprofen; Humans; Metoclopramide; Migraine Disorders; Naproxen; ortho-Aminobenzoates; Randomized Controlled Trials as Topic | 1992 |
Stereoselective metabolism of anti-inflammatory 2-arylpropionates.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Flurbiprofen; Ibuprofen; Naproxen; Stereoisomerism; Suprofen | 1990 |
The propionic acids. Gastrointestinal toxicity in various species.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Digestive System; Dogs; Fenoprofen; Flurbiprofen; Haplorhini; Ibuprofen; Naproxen; Propionates; Rats; Species Specificity | 1988 |
[A novel class of anti-inflammatory and analgesic drugs--NO-donating NSAIDs].
Topics: Acetaminophen; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiotonic Agents; Cyclooxygenase Inhibitors; Flurbiprofen; Gastrointestinal Diseases; Humans; Ibuprofen; Naproxen; Nitrates; Nitric Oxide Donors | 2007 |
Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years.
Topics: Adolescent; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Celecoxib; Child; Chronic Disease; Diclofenac; Flurbiprofen; Humans; Ibuprofen; Infant; Ketoprofen; Ketorolac; Meloxicam; Naproxen; Niflumic Acid; Pain | 2022 |
8 trial(s) available for flurbiprofen and naproxen
Article | Year |
---|---|
[Migraine and non-steroidal anti-inflammatory agents].
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diclofenac; Ergotamine; Flufenamic Acid; Flurbiprofen; Humans; Metoclopramide; Migraine Disorders; Naproxen; ortho-Aminobenzoates; Randomized Controlled Trials as Topic | 1992 |
A comparison of flurbiprofen and naproxen in the treatment of rheumatoid arthritis: a Canadian multi-centre study.
Topics: Adult; Aged; Arthritis, Rheumatoid; Disability Evaluation; Double-Blind Method; Female; Flurbiprofen; Humans; Male; Middle Aged; Multicenter Studies as Topic; Naproxen; Pain Measurement; Randomized Controlled Trials as Topic | 1990 |
A double-blind cross-over study comparing flurbiprofen with naproxen-sodium for the treatment of primary dysmenorrhea.
Topics: Adult; Double-Blind Method; Dysmenorrhea; Female; Flurbiprofen; Humans; Naproxen; Pain Measurement | 1989 |
The effect of flurbiprofen and naproxen sodium on intra-uterine pressure and menstrual pain in patients with primary dysmenorrhea.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Dysmenorrhea; Female; Flurbiprofen; Humans; Naproxen; Pain; Pressure; Propionates; Uterus | 1988 |
Flurbiprofen versus naproxen in the treatment of rheumatoid arthritis.
Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Flurbiprofen; Humans; Middle Aged; Naproxen; Propionates; Random Allocation | 1986 |
A multicentre comparison of flurbiprofen and naproxen in rheumatoid arthritis: a four-week study in 118 patients.
Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Female; Flurbiprofen; Humans; Male; Middle Aged; Naproxen; Propionates | 1983 |
A comparison of flurbiprofen with naproxen in ankylosing spondylitis.
Topics: Clinical Trials as Topic; Double-Blind Method; Female; Flurbiprofen; Gastrointestinal Diseases; Humans; Male; Naproxen; Propionates; Spondylitis, Ankylosing | 1980 |
Pain control during fixed orthodontic appliance therapy.
Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Facial Pain; Female; Flurbiprofen; Humans; Ibuprofen; Male; Naproxen; Orthodontic Appliances; Orthodontics, Corrective; Pain Measurement; Prospective Studies; Surveys and Questionnaires | 2005 |
92 other study(ies) available for flurbiprofen and naproxen
Article | Year |
---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Transport properties of nonsteroidal anti-inflammatory drugs by organic anion transporter 1 expressed in Xenopus laevis oocytes.
Topics: Animals; Anion Transport Proteins; Anti-Inflammatory Agents, Non-Steroidal; Biological Transport; Carrier Proteins; Oocytes; Xenopus laevis | 1999 |
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Nonsteroidal anti-inflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1.
Topics: Adenine; Anion Transport Proteins; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Biological Transport; Carrier Proteins; Humans; Kidney; Organophosphonates; Structure-Activity Relationship | 2000 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chamazulene carboxylic acid and matricin: a natural profen and its natural prodrug, identified through similarity to synthetic drug substances.
Topics: Achillea; Anti-Inflammatory Agents, Non-Steroidal; Azulenes; Carboxylic Acids; Cycloheptanes; Cyclooxygenase 1; Cyclooxygenase 2 Inhibitors; Germany; Lactones; Matricaria; Molecular Structure; Pharmaceutical Preparations; Prodrugs; Sesquiterpenes; Sesquiterpenes, Guaiane | 2006 |
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
Topics: Humans; Membranes, Artificial; Models, Biological; Models, Molecular; Octanols; Permeability; Pharmaceutical Preparations; Skin Absorption; Water | 2007 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Camphanes; Comet Assay; DNA Damage; Glucuronides; Glucuronosyltransferase; HEK293 Cells; Hepatocytes; Humans; Kidney | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests | 2012 |
Self-organizing molecular field analysis of NSAIDs: assessment of pharmacokinetic and physicochemical properties using 3D-QSPkR approach.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemical Phenomena; Computational Biology; Least-Squares Analysis; Models, Molecular; Molecular Conformation; Quantitative Structure-Activity Relationship | 2012 |
3-(3,4-Dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic Acids: highly potent and selective inhibitors of the type 5 17-β-hydroxysteroid dehydrogenase AKR1C3.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Benzoates; Enzyme Inhibitors; Humans; Hydroxyprostaglandin Dehydrogenases; Models, Molecular; Structure-Activity Relationship | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Inhibition of FAAH, TRPV1, and COX2 by NSAID-serotonin conjugates.
Topics: Amidohydrolases; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Flurbiprofen; Humans; Serotonin; TRPV Cation Channels | 2014 |
Novel triazolothiadiazines act as potent anticancer agents in liver cancer cells through Akt and ASK-1 proteins.
Topics: Antineoplastic Agents; Apoptosis; beta Catenin; Cell Line, Tumor; Cyclin D1; Cytoskeletal Proteins; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; HCT116 Cells; Hepatocytes; Humans; Inhibitory Concentration 50; MAP Kinase Kinase Kinase 5; MCF-7 Cells; Molecular Docking Simulation; Nuclear Proteins; Oxidative Stress; Protein Structure, Secondary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship; Signal Transduction; Thiadiazines; Triazoles | 2016 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Effects of NSAIDs on beagle crevicular cyclooxygenase metabolites and periodontal bone loss.
Topics: Administration, Oral; Administration, Topical; Alveolar Bone Loss; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Dinoprostone; Dogs; Flurbiprofen; Gingival Crevicular Fluid; Ibuprofen; Naproxen; Prostaglandins F; Thromboxane B2 | 1992 |
Glucuronidation of 3'-azido-3'-deoxythymidine in human liver microsomes: enzyme inhibition by drugs and steroid hormones.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Estrone; Ethinyl Estradiol; Flurbiprofen; Glucuronosyltransferase; Humans; Microsomes, Liver; Naproxen; Phenylpropionates; Probenecid; Testosterone; Zidovudine | 1992 |
Pseudoallergic reactions to nonsteroidal anti-inflammatory drugs.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diclofenac; Drug Eruptions; Female; Flurbiprofen; Humans; Naproxen | 1991 |
Relationship between aldose reductase inhibiting activity and anti-cataract action of various non-steroidal anti-inflammatory drugs.
Topics: Aldehyde Reductase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cataract; Flurbiprofen; Galactose; Lens, Crystalline; Naproxen; Ophthalmic Solutions; Piroxicam; Rats; Sulindac | 1991 |
The effects of cyclodextrins on the disposition of intravenously injected drugs in the rat.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; beta-Cyclodextrins; Blood Proteins; Cyclodextrins; Flurbiprofen; Injections, Intravenous; Male; Naproxen; Rats; Rats, Inbred Strains; Tissue Distribution | 1991 |
Inhibition of human periodontal prostaglandin E2 synthesis with selected agents.
Topics: Arachidonic Acid; Arachidonic Acids; Chromatography, High Pressure Liquid; Cyclooxygenase Inhibitors; Dinoprostone; Eicosapentaenoic Acid; Flurbiprofen; Humans; Ibuprofen; Ketoprofen; Meclofenamic Acid; Naproxen; Periodontitis; Periodontium; Vitamin E | 1990 |
Metabolic chiral inversion of anti-inflammatory 2-arylpropionates: lack of reaction in liver homogenates, and study of methine proton acidity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Flurbiprofen; Guinea Pigs; Ibuprofen; Isomerism; Kinetics; Liver; Male; Naproxen; Protons; Rats; Rats, Inbred Strains; Suprofen | 1988 |
Cell damage unmasks 15-lipoxygenase activity in human neutrophils.
Topics: Acetates; Arachidonate Lipoxygenases; Aspirin; Dose-Response Relationship, Drug; Etodolac; Fluorometry; Flurbiprofen; Humans; Hydroxyeicosatetraenoic Acids; Ibuprofen; L-Lactate Dehydrogenase; Lipoxygenase; Naproxen; Neutrophils; Phenylbutazone | 1985 |
Flurbiprofen is as effective as naproxen in juvenile spondylitis.
Topics: Adolescent; Child; Female; Flurbiprofen; Humans; Male; Naproxen; Propionates; Spondylitis | 1986 |
European experience with flurbiprofen. A new analgesic/anti-inflammatory agent.
Topics: Aspirin; Drug Evaluation; Europe; Flurbiprofen; Humans; Ibuprofen; Indomethacin; Naproxen; Propionates | 1986 |
High-performance liquid chromatographic separation of the enantiomers of anti-inflammatory 2-arylpropionates: suitability of the method for in vitro metabolic studies.
Topics: Animals; Anti-Inflammatory Agents; Chromatography, High Pressure Liquid; Drug Stability; Flurbiprofen; In Vitro Techniques; Liver; Naproxen; Propionates; Rats; Stereoisomerism | 1984 |
Arachidonic acid metabolites and the gastro-intestinal toxicity of anti-inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Aspirin; Cyclooxygenase Inhibitors; Digestive System; Flurbiprofen; Gastric Mucosa; Indomethacin; Intestinal Mucosa; Ketoprofen; Naproxen; Prostaglandins; Rats | 1981 |
Alterations in the electroretinogram of newborn piglets by propionic acid-derivative nonsteroidal antiinflammatory drugs but not by indomethacin and diclofenac.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Electroretinography; Flurbiprofen; Ibuprofen; Indomethacin; Naproxen; Photoreceptor Cells; Propionates; Prostaglandins; Retina; Swine | 1995 |
Evaluation of the macrocyclic antibiotic vancomycin as a chiral selector for capillary electrophoresis.
Topics: Amino Acid Sequence; Amino Acids; Carbazoles; Carboxylic Acids; Electrophoresis; Flurbiprofen; Hydrogen-Ion Concentration; Molecular Sequence Data; Naproxen; Peptides, Cyclic; Stereoisomerism; Vancomycin | 1994 |
Intravenous microdialysis in the mouse and the rat: development and pharmacokinetic application of a new probe.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Catheterization, Central Venous; Flurbiprofen; Male; Mice; Mice, Inbred Strains; Microdialysis; Naproxen; Online Systems; Rats; Rats, Wistar; Telemetry; Vena Cava, Inferior | 1996 |
Serum protein binding of nonsteroidal antiinflammatory drugs: a comparative study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Chromatography, High Pressure Liquid; Diclofenac; Female; Fenoprofen; Flurbiprofen; Humans; Ketoprofen; Male; Middle Aged; Naproxen; Protein Binding; Tolmetin | 1997 |
Effect of chemical structure on the release of certain propionic acid derivatives from their dosage forms.
Topics: Capsules; Chemical Phenomena; Chemistry, Physical; Dosage Forms; Drug Compounding; Drug Stability; Drug Storage; Flurbiprofen; Humans; Ibuprofen; Ketoprofen; Molecular Structure; Naproxen; Propionates; Suppositories | 1998 |
Nitric oxide-releasing NSAIDs inhibit interleukin-1beta converting enzyme-like cysteine proteases and protect endothelial cells from apoptosis induced by TNFalpha.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Caspase Inhibitors; Cell Line; Cysteine Proteinase Inhibitors; DNA Fragmentation; Endothelium, Vascular; Flurbiprofen; Gastric Mucosa; Humans; In Situ Nick-End Labeling; Male; Mice; Naproxen; Nitric Oxide; Peroxidase; Rats; Rats, Wistar | 1999 |
Dapsone activation of CYP2C9-mediated metabolism: evidence for activation of multiple substrates and a two-site model.
Topics: Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 Enzyme System; Dapsone; Enzyme Activation; Flurbiprofen; Hydroxylation; Models, Chemical; Naproxen; Piroxicam; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Substrate Specificity | 2001 |
Palladium-catalyzed alpha-arylation of esters.
Topics: Acetates; Anti-Inflammatory Agents, Non-Steroidal; Bromides; Catalysis; Esters; Flurbiprofen; Lithium; Molecular Structure; Naproxen; Organosilicon Compounds; Palladium; Phosphines | 2001 |
Molecular modelling of the differential interaction between several non-steroidal anti-inflammatory drugs and human prostaglandin endoperoxide H synthase-2 (h-PGHS-2).
Topics: Anti-Inflammatory Agents, Non-Steroidal; Computer Graphics; Computer Simulation; Crystallography, X-Ray; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Energy Transfer; Flurbiprofen; Humans; Indomethacin; Isoenzymes; Ketoprofen; Meclofenamic Acid; Mefenamic Acid; Membrane Proteins; Models, Molecular; Naproxen; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides | 2002 |
Polymorphic variants (CYP2C9*3 and CYP2C9*5) and the F114L active site mutation of CYP2C9: effect on atypical kinetic metabolism profiles.
Topics: Alleles; Amino Acid Substitution; Anti-Inflammatory Agents, Non-Steroidal; Aryl Hydrocarbon Hydroxylases; Binding Sites; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Flurbiprofen; Humans; Kinetics; Mutation; Naproxen; Piroxicam; Polymorphism, Genetic; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Structure-Activity Relationship; Substrate Specificity | 2002 |
Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Dinoprostone; Flurbiprofen; Gastrointestinal Motility; Indomethacin; Intestinal Mucosa; Intestine, Small; Male; Naproxen; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxidase; Rats; Rats, Sprague-Dawley | 2002 |
Activation of CYP2C9-mediated metabolism by a series of dapsone analogs: kinetics and structural requirements.
Topics: Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C9; Dapsone; Dealkylation; Flurbiprofen; Hydroxylation; Kinetics; Naproxen; Structure-Activity Relationship; Substrate Specificity | 2002 |
[Chiral separation of naproxen and flurbiprofen by capillary electrophoresis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Cyclodextrins; Electrophoresis, Capillary; Flurbiprofen; Naproxen; Stereoisomerism | 2000 |
Differential activation of CYP2C9 variants by dapsone.
Topics: Alleles; Anti-Inflammatory Agents, Non-Steroidal; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C9; Dapsone; Enzyme Activation; Flurbiprofen; Humans; Hydroxylation; Kinetics; Naproxen; Substrate Specificity | 2004 |
Calculation of cyclodextrin binding affinities: energy, entropy, and implications for drug design.
Topics: Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Benzene; Binding Sites; Butanones; Computer Simulation; Cyclodextrins; Drug Delivery Systems; Drug Design; Energy Transfer; Entropy; Flurbiprofen; Kinetics; Models, Chemical; Models, Molecular; Molecular Conformation; Nabumetone; Naproxen; Resorcinols | 2004 |
NSAIDs increase GM-CSF release by human synoviocytes: comparison with nitric oxide-donating derivatives.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blotting, Western; Cells, Cultured; Cyclic AMP; Cyclic GMP; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Flurbiprofen; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Indomethacin; Membrane Proteins; Naproxen; Nitric Oxide Donors; Nitroprusside; Phosphodiesterase Inhibitors; Prostaglandin-Endoperoxide Synthases; Purinones; Synovial Membrane; Time Factors | 2005 |
Reversal of elution order for profen acid enantiomers in packed-column SFC on Chiralpak AD.
Topics: 2-Propanol; Alcohols; Amylose; Butanols; Carbon Dioxide; Cellulose; Chromatography; Chromatography, Supercritical Fluid; Citric Acid; Ethanol; Flurbiprofen; Magnetic Resonance Spectroscopy; Models, Chemical; Naproxen; Pentanols; Phenylcarbamates; Propionates; Silicon Dioxide; Stereoisomerism; Temperature; Ultraviolet Rays | 2005 |
Factors involved in upregulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal anti-inflammatory drugs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Disease Models, Animal; Enterobacteriaceae; Flurbiprofen; Gastrointestinal Motility; Indomethacin; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Lactones; Male; Naproxen; Nitric Oxide; Nitric Oxide Synthase Type II; Pyrazoles; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sulfones; Time Factors; Up-Regulation | 2006 |
Factors affecting the formation of eutectic solid dispersions and their dissolution behavior.
Topics: Drug Carriers; Fenofibrate; Flurbiprofen; Griseofulvin; Ibuprofen; Models, Chemical; Molecular Weight; Naproxen; Polyethylene Glycols; Sodium Dodecyl Sulfate; Solubility; Transition Temperature; Water | 2007 |
Non-carboxylic analogues of arylpropionic acids: synthesis, anti-inflammatory activity and ulcerogenic potential.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Flurbiprofen; Ibuprofen; Male; Naproxen; Propionates; Rats; Stomach Ulcer; Structure-Activity Relationship; Thiadiazoles; Thiazoles | 2007 |
Electrokinetic migration of acidic drugs across a supported liquid membrane.
Topics: Acids; Chromatography, Micellar Electrokinetic Capillary; Electrophoresis, Capillary; Flurbiprofen; Gemfibrozil; Heptanol; Hydrogen-Ion Concentration; Ketoprofen; Membranes, Artificial; Naproxen; Pharmaceutical Preparations; Probenecid; Reproducibility of Results; Warfarin | 2007 |
Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspartic Acid; Buffers; Chromatography, High Pressure Liquid; Colon; Cyclodextrins; Drug Carriers; Drug Delivery Systems; Flurbiprofen; Gastrointestinal Transit; Hydrogen-Ion Concentration; Hydrolysis; In Vitro Techniques; Inflammatory Bowel Diseases; Male; Naproxen; Prodrugs; Rats; Sulindac | 2008 |
Ionic liquid-based dynamic liquid-phase microextraction: application to the determination of anti-inflammatory drugs in urine samples.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemical Fractionation; Flurbiprofen; Humans; Hydrogen-Ion Concentration; Indomethacin; Ionic Liquids; Ketoprofen; Molecular Structure; Naproxen; Phenylbutyrates; Reproducibility of Results; Tolmetin | 2008 |
Nanocomposites of 2-arylpropionic acid drugs based on Mg-Al layered double hydroxide for dissolution enhancement.
Topics: Aluminum Hydroxide; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Differential Thermal Analysis; Excipients; Flurbiprofen; L-Lactate Dehydrogenase; Magnesium Hydroxide; Nanoparticles; Naproxen; Solubility; Spectrophotometry, Infrared; X-Ray Diffraction | 2008 |
Enantiomeric separation of acidic compounds by nano-liquid chromatography with methylated-beta-cyclodextrin as a mobile phase additive.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzoxazoles; beta-Cyclodextrins; Carbazoles; Chromatography, Liquid; Flurbiprofen; Hydrogen-Ion Concentration; Indoprofen; Ketoprofen; Methylation; Molecular Structure; Nanotechnology; Naproxen; Propionates; Stereoisomerism; Suprofen; Time Factors | 2009 |
Differences in the interaction between aryl propionic acid derivatives and poly(vinylpyrrolidone) K30: A multi-methodological approach.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Carbon Isotopes; Crystallization; Drug Stability; Flurbiprofen; Hot Temperature; Humidity; Hydrogen Bonding; Ibuprofen; Ketoprofen; Magnetic Resonance Spectroscopy; Molecular Structure; Molecular Weight; Naproxen; Phase Transition; Phenylbutyrates; Polymers; Povidone; Static Electricity; X-Ray Diffraction | 2009 |
Simultaneous dissolution of naproxen and flurbiprofen from a novel ternary gamma-cyclodextrin complex.
Topics: Chemistry, Pharmaceutical; Flurbiprofen; gamma-Cyclodextrins; Molecular Structure; Naproxen; Solubility; Water; X-Ray Diffraction | 2010 |
Structural evaluation of crystalline ternary γ-cyclodextrin complex.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Chemical Precipitation; Excipients; Flurbiprofen; gamma-Cyclodextrins; Ketoprofen; Magnetic Resonance Spectroscopy; Molecular Conformation; Naproxen; Pharmaceutic Aids; Powder Diffraction; Salicylic Acid; Spectroscopy, Fourier Transform Infrared; Water | 2011 |
Stereoselective inhibitory effect of flurbiprofen, ibuprofen and naproxen on human organic anion transporters hOAT1 and hOAT3.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Flurbiprofen; Humans; Ibuprofen; Inhibitory Concentration 50; Naproxen; Oocytes; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Stereoisomerism; Xenopus laevis | 2011 |
Determination of non-steroidal anti-inflammatory drugs in urine by the combination of stir membrane liquid-liquid-liquid microextraction and liquid chromatography.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chromatography, Liquid; Flurbiprofen; Humans; Indomethacin; Ketoprofen; Limit of Detection; Liquid Phase Microextraction; Naproxen | 2012 |
Crystal structures of three classes of non-steroidal anti-inflammatory drugs in complex with aldo-keto reductase 1C3.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Anti-Inflammatory Agents, Non-Steroidal; Flufenamic Acid; Flurbiprofen; Hydroxyprostaglandin Dehydrogenases; Ibuprofen; Indomethacin; Meclofenamic Acid; Mefenamic Acid; Naproxen; Sulindac; Tolmetin | 2012 |
Sensing chiral drugs by using CdSe/ZnS nanoparticles capped with N-acetyl-L-cysteine methyl ester.
Topics: Acetylcysteine; Cadmium Compounds; Circular Dichroism; Esters; Flurbiprofen; Ibuprofen; Ketoprofen; Naproxen; Pharmaceutical Preparations; Quantum Dots; Selenium Compounds; Spectrometry, Fluorescence; Stereoisomerism; Sulfides; Zinc Compounds | 2013 |
Pre-existent asymmetry in the human cyclooxygenase-2 sequence homodimer.
Topics: Acetylation; Amino Acid Sequence; Amino Acid Substitution; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Aspirin; Celecoxib; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Flurbiprofen; Guanidine; Heme; Humans; Indomethacin; Kinetics; Models, Biological; Mutant Proteins; Mutation; Naproxen; Oxygen; Palmitic Acid; Peroxidase; Protein Multimerization; Pyrazoles; Substrate Specificity; Sulfonamides | 2013 |
Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen.
Topics: Amides; Amidohydrolases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Cell Line, Tumor; Cyclooxygenase Inhibitors; Flurbiprofen; Male; Naproxen; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1 | 2013 |
Determination of thermodynamic values of acidic dissociation constants and complexation constants of profens and their utilization for optimization of separation conditions by Simul 5 Complex.
Topics: Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Computer Simulation; Electrophoresis, Capillary; Flurbiprofen; Hydrogen-Ion Concentration; Ibuprofen; Ketoprofen; Magnetic Resonance Spectroscopy; Naproxen; Osmolar Concentration; Software; Thermodynamics; Viscosity | 2014 |
Marginally designed new profen analogues have the potential to inhibit cyclooxygenase enzymes.
Topics: Arachidonate 5-Lipoxygenase; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Design; Flurbiprofen; Ibuprofen; Lipoxygenase Inhibitors; Molecular Structure; Naproxen; Propionates; Structure-Activity Relationship | 2015 |
[[Chiral separation of five arylpropionic acid drugs and determination of their enantiomers in pharmaceutical preparations by reversed-phase high performance liquid chromatography with cellulose-tris-(4-methylbenzoate) stationary phase]].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzoates; Benzopyrans; Cellulose; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Flurbiprofen; Ibuprofen; Naproxen; Phenylpropionates; Propionates; Stereoisomerism | 2014 |
Self-assembly of amphiphilic anionic calix[4]arenes and encapsulation of poorly soluble naproxen and flurbiprofen.
Topics: Anions; Calixarenes; Dynamic Light Scattering; Flurbiprofen; Magnetic Resonance Spectroscopy; Micelles; Microscopy, Atomic Force; Molecular Structure; Naproxen; Solubility; Surface-Active Agents | 2015 |
Cyclosporin A-sensitive cytotoxicity of flurbiprofen non-stereoselectively mediated by cytochrome P450 metabolism in three-dimensional cultured rat hepatocytes.
Topics: Adenosine Triphosphate; Animals; Chemical and Drug Induced Liver Injury; Cyclosporine; Cytochrome P-450 Enzyme System; Flurbiprofen; Hepatocytes; Ibuprofen; L-Lactate Dehydrogenase; Male; Mitochondria; Naproxen; Phenylpropionates; Rats; Rats, Wistar; Stereoisomerism | 2015 |
Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cell Line; Cell Survival; Cyclooxygenase 2; Drug Stability; Flurbiprofen; Gene Expression; Humans; Interleukin-1beta; Naproxen; Peptide Fragments; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Thioctic Acid; Tumor Necrosis Factor-alpha | 2016 |
Enantioselective simultaneous analysis of selected pharmaceuticals in environmental samples by ultrahigh performance supercritical fluid based chromatography tandem mass spectrometry.
Topics: Aminorex; Carbazoles; Chloramphenicol; Chromatography, High Pressure Liquid; Chromatography, Supercritical Fluid; Flurbiprofen; Humans; Ibuprofen; Ifosfamide; Imidazoles; Indoprofen; Molecular Structure; Naproxen; Ofloxacin; Omeprazole; Praziquantel; Solid Phase Extraction; Stereoisomerism; Tandem Mass Spectrometry; Tetramisole; Water Pollutants, Chemical | 2016 |
Effect of guest drug character encapsulated in the cavity and intermolecular spaces of γ-cyclodextrins on the dissolution property of ternary γ-cyclodextrin complex.
Topics: Chemistry, Pharmaceutical; Drug Carriers; Flurbiprofen; gamma-Cyclodextrins; Ketoprofen; Naproxen; Salicylamides; Solubility | 2017 |
Photochemically Controlled Drug Dosing from a Polymeric Scaffold.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Carriers; Drug Liberation; Flurbiprofen; Humans; Naproxen; Photochemical Processes; Photolysis; Polymethacrylic Acids; Ultraviolet Rays | 2017 |
The nature of hydrogen-bonding interactions in nonsteroidal anti-inflammatory drugs revealed by polarized IR spectroscopy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Crystallography, X-Ray; Deuterium; Flurbiprofen; Hydrogen Bonding; Ketoprofen; Naproxen; Spectrophotometry, Infrared; Vibration | 2018 |
Levetiracetam+nonsteroidal anti-inflammatory drug binary systems: A contribution to the development of new solid dosage forms.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Drug Combinations; Drug Liberation; Flurbiprofen; Ibuprofen; Ketoprofen; Levetiracetam; Naproxen; Piracetam; Stereoisomerism | 2017 |
Correlation between glucuronidation and covalent adducts formation with proteins of nonsteroidal anti-inflammatory drugs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzopyrans; Flurbiprofen; Glucuronides; Ibuprofen; Ketoprofen; Male; Microsomes, Liver; Naproxen; Propionates; Protein Binding; Rats, Wistar | 2018 |
Simultaneous enantiomeric analysis of non-steroidal anti-inflammatory drugs in environment by chiral LC-MS/MS: A pilot study in Beijing, China.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Beijing; Chromatography, High Pressure Liquid; Environmental Monitoring; Flurbiprofen; Ibuprofen; Naproxen; Pilot Projects; Rivers; Stereoisomerism; Tandem Mass Spectrometry; Water Pollutants, Chemical | 2019 |
Formation of Drug-Participating Catanionic Aggregates for Extended Delivery of Non-Steroidal Anti-Inflammatory Drugs from Contact Lenses.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cations; Contact Lenses; Diclofenac; Diffusion; Drug Delivery Systems; Drug Liberation; Fatty Alcohols; Flurbiprofen; Hydrophobic and Hydrophilic Interactions; Kinetics; Naproxen; Quaternary Ammonium Compounds; Surface-Active Agents; Viscosity | 2019 |
Efficient Palladium-Catalyzed Synthesis of 2-Aryl Propionic Acids.
Topics: Catalysis; Flurbiprofen; Naproxen; Palladium | 2020 |
Cisplatin-cyclooxygenase inhibitor conjugates, free and immobilised in mesoporous silica SBA-15, prove highly potent against triple-negative MDA-MB-468 breast cancer cell line.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cisplatin; Cyclooxygenase Inhibitors; Female; Flurbiprofen; Humans; Ibuprofen; Molecular Structure; Naproxen; Platinum; Silicon Dioxide | 2022 |
Chiral Inversion of 2-Arylpropionic Acid Enantiomers under Anaerobic Conditions.
Topics: Anaerobiosis; Anti-Inflammatory Agents, Non-Steroidal; Flurbiprofen; Naproxen; Stereoisomerism | 2022 |
Masking the Taste of Fixed-Dose Combination Drugs: Particular NSAIDs Can Efficiently Mask the Bitterness of Famotidine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Famotidine; Flurbiprofen; Ibuprofen; Naproxen; Taste | 2023 |
Preparation and chromatographic performance of chiral peptide-based stationary phases for enantiomeric separation.
Topics: Chromatography, High Pressure Liquid; Flurbiprofen; Naproxen; Reproducibility of Results; Stereoisomerism | 2023 |